VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 19 filers reported holding VIRPAX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,203 | -45.8% | 292,790 | -26.8% | 0.17% | -51.6% |
| Q2 2023 | $432,000 | -21.5% | 400,000 | -43.0% | 0.35% | -26.5% |
| Q1 2023 | $550,642 | -10.5% | 701,455 | -29.0% | 0.48% | -10.9% |
| Q4 2022 | $614,935 | -51.0% | 988,165 | -6.3% | 0.54% | -66.0% |
| Q3 2022 | $1,255,000 | -29.5% | 1,054,400 | -0.5% | 1.58% | +30.7% |
| Q2 2022 | $1,780,000 | -90.3% | 1,059,383 | +5.4% | 1.21% | -55.8% |
| Q1 2022 | $18,339,000 | +509.7% | 1,005,156 | +14.6% | 2.74% | +526.5% |
| Q4 2021 | $3,008,000 | -36.9% | 876,834 | -11.7% | 0.44% | -32.1% |
| Q3 2021 | $4,766,000 | +577.0% | 993,000 | +541.7% | 0.64% | +550.5% |
| Q2 2021 | $704,000 | -25.3% | 154,737 | -22.6% | 0.10% | -45.9% |
| Q1 2021 | $942,000 | – | 200,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 988,165 | $614,935 | 0.54% |
| Quantum Private Wealth, LLC | 10,000 | $6,223 | 0.00% |
| Warberg Asset Management LLC | 17,012 | $10,561 | 0.00% |
| Belpointe Asset Management LLC | 19,045 | $11,852 | 0.00% |
| OSAIC HOLDINGS, INC. | 600 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 100,875 | $62,744 | 0.00% |
| WELLS FARGO & COMPANY/MN | 59 | $37 | 0.00% |
| NORTHERN TRUST CORP | 15,221 | $9,472 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 66,038 | $41 | 0.00% |